Soft Tissue Sarcoma – Soft tissue sarcoma is a type of cancer that begins in the soft tissues of the body, such as muscles, fat, blood vessels, nerves, tendons, and the lining of the joints. It can occur anywhere in the body but is most commonly found in the arms, legs, and abdomen. The disease often starts as a painless lump or swelling and may grow slowly or rapidly. As it progresses, it can cause pain or interfere with normal body functions, depending on its location. Soft tissue sarcomas are a diverse group of cancers, with many different subtypes, each with its own characteristics. The progression and behavior of the disease can vary significantly based on the specific type and location of the sarcoma.
Non-Small Cell Lung Cancer (NSCLC) – Non-small cell lung cancer is the most common type of lung cancer, accounting for about 85% of cases. It typically starts in the epithelial cells lining the lungs and can grow and spread to other parts of the body. The disease often develops slowly and may not cause symptoms until it is advanced. Common symptoms include a persistent cough, chest pain, and shortness of breath. NSCLC is categorized into several subtypes, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, each with distinct characteristics. The progression of NSCLC can vary, with some tumors growing slowly and others spreading more quickly.
Triple Negative Breast Cancer (TNBC) – Triple negative breast cancer is a type of breast cancer that lacks the three most common types of receptors known to fuel most breast cancer growth: estrogen, progesterone, and the HER-2/neu gene. This makes it more challenging to treat, as hormone therapies and drugs that target HER-2 are ineffective. TNBC tends to be more aggressive and is more likely to spread and recur than other types of breast cancer. It often affects younger women and is more common in women with a BRCA1 gene mutation. The disease typically presents as a lump in the breast and may progress rapidly, requiring prompt medical attention.
Microsatellite Stable Colorectal Cancer (MSS-CRC) – Microsatellite stable colorectal cancer is a subtype of colorectal cancer characterized by the absence of microsatellite instability, a condition of genetic hypermutability. This type of cancer is more common than its counterpart, microsatellite instability-high (MSI-H) colorectal cancer. MSS-CRC usually follows a more traditional pathway of cancer development, often associated with chromosomal instability. It can start as a benign polyp in the colon or rectum and gradually progress to cancer over time. Symptoms may include changes in bowel habits, blood in the stool, and abdominal discomfort. The progression of MSS-CRC can vary, with some cases remaining localized while others may spread to distant organs.
Biliary Tract Cancer (BTC) – Biliary tract cancer is a group of cancers that occur in the bile ducts, gallbladder, or ampulla of Vater. These cancers are relatively rare and can be challenging to diagnose early due to their location and nonspecific symptoms. BTC often presents with symptoms such as jaundice, abdominal pain, and weight loss. The disease can progress by invading nearby structures or spreading to distant organs. Biliary tract cancers are classified based on their location, including intrahepatic, perihilar, and distal bile duct cancers, each with unique characteristics. The progression and behavior of BTC can vary, with some tumors growing slowly and others spreading more aggressively.
France 
